MoneyWorks4Me

Gujarat Terce Laboratories informs about outcome of board meeting

26 Feb 2020 Evaluate

Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Gujarat Terce Laboratories has informed that the Board of Directors of the Company, at its Meeting held today on Wednesday, 26th February, 2020 which commenced at 12:00 pm and concluded at 2:30 pm, have approved the appointment of Navinchandra Patel (DIN:08702502) as an Additional Independent Director in the Company with effect from February 26, 2020.

The above information is a part of company’s filings submitted to BSE.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1849.80
Dr. Reddys Labs. 1200.65
Cipla 1404.00
Lupin 2085.90
Zydus Lifesciences 1194.20
View more..